[
  {
    "ts": "2025-12-21T15:26:30+00:00",
    "headline": "Jim Cramer Discusses Kura Oncology as a Speculative Bet",
    "summary": "Kura Oncology, Inc. (NASDAQ:KURA) is one of the stocks Jim Cramer offered insights on. When a caller highlighted the company’s $135 million milestone payment owing to its U.S. commercial sale of KOMZIFTI, Cramer commented: “That’s a lot. That is a lot… Now, just understand that, yeah, they are milestone payments, not actual. Now, here’s what […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-discusses-kura-oncology-152630645.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "7b246c25-8785-3ea4-9646-259ab0f7d8e9",
      "content": {
        "id": "7b246c25-8785-3ea4-9646-259ab0f7d8e9",
        "contentType": "STORY",
        "title": "Jim Cramer Discusses Kura Oncology as a Speculative Bet",
        "description": "",
        "summary": "Kura Oncology, Inc. (NASDAQ:KURA) is one of the stocks Jim Cramer offered insights on. When a caller highlighted the company’s $135 million milestone payment owing to its U.S. commercial sale of KOMZIFTI, Cramer commented: “That’s a lot. That is a lot… Now, just understand that, yeah, they are milestone payments, not actual. Now, here’s what […]",
        "pubDate": "2025-12-21T15:26:30Z",
        "displayTime": "2025-12-21T15:26:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/92264ef32b70332cc4ea9283d978e1a6",
          "originalWidth": 6538,
          "originalHeight": 4359,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RYQ.uW7wwp9a4kdxC.OBbQ--~B/aD00MzU5O3c9NjUzODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/92264ef32b70332cc4ea9283d978e1a6.cf.webp",
              "width": 6538,
              "height": 4359,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2i4a98C_B2YJXhctyiN1Vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/92264ef32b70332cc4ea9283d978e1a6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-kura-oncology-152630645.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-kura-oncology-152630645.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KURA"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]